
公司名稱:傑基興業股份有限公司
攤位號碼:1466










Dr. Son Young Whee, DDS, MSD, PhD. (韓國京畿道牙醫師公會)
學經歷
Graduated from Chonnam National University College of Dentistry
Trained at Department of Oral and Maxillofacial Surgery, Chonnam National University Hospital
PhD, College of Dentistry, Chonnam National University
Adjunct professor, Department of Dentistry, College of Medicine, Hallym University
Senior Advisor, Advanced Implant Research Association
Vice-president, Gyeonggi Dental Association
Director, e-Good Dental Clinic
摘要
As dental implant treatment has become more widespread, it is now regarded as a common treatment method for addressing tooth loss. Since dental implants are placed into the extracted alveolar bone, the condition of the alveolar bone and the amount of available bone determine the difficulty of the procedure. Securing sufficient hard tissue around the implant mainly influences its long-term stability. The condition of the residual alveolar ridge varies among patients depending on the cause of extraction and the time elapsed before implant placement. Placing implants in severely resorbed alveolar bone and creating new bone is generally very challenging, requires a long treatment period, and demands careful selection of graft materials and barrier membranes. In this lecture, we will discuss considerations for hard tissue reconstruction in patients with moderate to severe horizontal and vertical bone defects, surgical precautions, and methods to simplify complex and difficult procedures.

Dr. Hirohiko Hirano, D.D.S., Ph.D. (日本埼玉縣齒科醫師會)
學經歷
Education
NIHON UNIVERSITY School of Dentistry at Matsudo
Academic Appointments
1.Visiting Professor, Nihon University
Present Position
1.Director: Dentistry and Oral Surgery
2.Team Leader: Research Team for Promoting Independence and Mental Health
Professional Experience
1992-2002 Medical Staff of Dental and Oral Surgery, Tokyo Metropolitan Geriatric Hospital (TMGH)
2002-2009 Medical Director of Dental and Oral Surgery, TMGH
2009-2016 Sub-director of Tokyo Metropolitan Institute of Gerontology (TMIG)
2016-2018 Director of Dental and Oral Surgery, TMGH
2019-2022 Director of Dental and Oral Surgery, TMGH & Director of Research Team for Promoting Independence and Mental Health, TMIG
In the current position since 2023.
Professional Affiliation / Membership
1.Japanese Society of Gerodontology (President)
2.The Japan Federation of Gerontological Societies (Director)
3.Japanese Association on Sarcopenia and Frailty (Director)
4.Japanese Society for Evidence and the Dental Professional (Director)
5.Dept. of Community Health, Japan Dental Association
Major interest
Gerodontology、Oral Frailty、Nutritional support for people with dementia
摘要
In Japan, oral hypofunction in older adults and oral function developmental disorder in children were officially established as diagnostic categories covered by the public health insurance system in 2018. In addition, the Ministry of Health, Labour and Welfare has clearly emphasized that the role of the family dentist extends beyond the management of dental caries and periodontal disease to include the acquisition, maintenance, and restoration of oral function. As a result, the importance of oral function management has gained increasing attention.
Assessment of oral hypofunction is conducted using seven examination items: poor oral hygiene, oral dryness, decreased occlusal force, reduced tongue–lip motor function, low tongue pressure, impaired masticatory function, and impaired swallowing function. Individuals who meet three or more of these criteria are diagnosed with oral hypofunction and are managed through comprehensive oral function management. However, unlike diseases such as dental caries and periodontal disease, which are associated with visible structural changes, oral function represents an intrinsic and functional condition. Consequently, many dental professionals find it challenging to form a concrete clinical image of oral function management.
In this lecture, methods for assessing oral function in older adults, interpretation of assessment results, and practical approaches to oral function management will be explained. Actual clinical cases will also be presented to illustrate real-world application.


公司名稱:鐿鈦科技股份有限公司
攤位號碼:1165
公司官網及社群:
ROYAL-DENT 植體系統通過中國大陸CFDA、美國FDA、歐盟CE、新加坡HAS及臺灣衛服部查驗登記,由國內知名專為國際醫療器材大廠生產之優良上市櫃製造廠「鐿鈦科技」所生產。鐿鈦科技公司長期致力於醫療產業技術與專業之精進創新,深獲國際第一醫材大廠所肯定,深耕且累積三十年以上卓越醫療器材製造技術。
源自鐿鈦科技的 ROYAL-DENT 植體系統,秉持一貫的嚴謹製程,應用先進植體表面技術,加上即時專業服務支援體系,讓牙醫師得以安心提供患者無後顧之憂的治療,深獲牙醫界的肯定與信賴。
ROYAL-DENT 以「 Beyond Your Smile 」為品牌承諾,以幫助患者恢復口腔健康、重拾自信笑容為使命,持續提供優良、穩定的產品。








